Table 2.
Characteristics of patient participants
| Overall (n=79) | SO (n=42) | SUSIT (n=37) | p-value1 | |
|---|---|---|---|---|
| Characteristic | N (%) | N (%) | N (%) | |
| Clinic type | 0.163 | |||
| Primary care | 31 (39.2) | 20 (47.6) | 11 (29.7) | |
| HIV | 48 (60.8) | 22 (52.4) | 26 (70.3) | |
| Gender | 0.006 | |||
| Male | 60 (75.9) | 27 (64.3) | 33 (89.2) | |
| Female | 18 (22.8) | 15 (35.7) | 3 (8.1) | |
| Other | 1 (1.3) | 0 (0.0) | 1 (2.7) | |
| Age | 0.814 | |||
| Mean (SD) | 45.4 (13.4) | 45.7 (13.8) | 45.0 (13.1) | |
| Median [Min, Max] | 44.0 [20.0, 73.0] | 45.0 [20.0, 70.0] | 43.5 [24.0, 73.0] | |
| Race/Ethnicity | 0.992 | |||
| Black | 24 (30.4) | 12 (28.6) | 12 (32.4) | |
| White | 15 (19.0) | 7 (16.7) | 8 (21.6) | |
| Asian | 1 (1.3) | 1 (2.4) | 0 (0.0) | |
| Hispanic/Latinx | 28 (35.4) | 15 (35.7) | 13 (35.1) | |
| Other | 6 (7.6) | 3 (7.1) | 3 (8.1) | |
| Missing/Refused | 5 (6.3) | 4 (9.5) | 1 (2.7) | |
| Education | 0.166 | |||
| High school or less | 31 (39.2) | 13 (31.0) | 18 (48.6) | |
| More than high school | 48 (60.8) | 29 (69.0) | 19 (51.4) | |
| Mental health | ||||
| Anxiety (GAD score ≥9) | 15 (19.0) | 10 (23.8) | 5 (13.5) | 0.268 |
| Depression (PHQ-8 score ≥9)2 | 17 (21.5) | 11 (26.2) | 6 (16.2) | 0.345 |
| Moderate-risk Substance Use 3 | ||||
| Tobacco | 35 (44.3) | 22 (52.4) | 13 (35.1) | 0.189 |
| Alcohol | 17 (21.5) | 10 (23.8) | 7 (18.9) | 0.800 |
| Marijuana | 73 (92.4) | 38 (90.5) | 35 (94.6) | 0.792 |
| Inhalants | 13 (16.4) | 3 (7.1) | 10 (27.0) | 0.031 |
| Cocaine | 12 (15.2) | 6 (14.3) | 6 (16.2) | 1.000 |
| Hallucinogens | 10 (12.7) | 5 (11.9) | 5 (13.5) | 1.000 |
| Prescription sedatives | 10 (12.7) | 5 (11.9) | 5 (13.5) | 1.000 |
| Methamphetamine | 8 (10.1) | 3 (7.1) | 5 (13.5) | 0.463 |
| Prescription stimulants | 5 (6.3) | 1 (2.4) | 4(10.8) | 0.182 |
| Heroin | 3 (3.8) | 3 (7.1) | 0 (0) | 0.243 |
| Prescription Opioids | 3 (3.8) | 2 (4.8) | 1 (2.7) | 1.000 |
| >1 drug (excluding tobacco and alcohol) | 30 (38.0) | 14 (33.3) | 16 (43.2) | 0.501 |
| Drug of Most Concern (DOMC) | 0.271 | |||
| Marijuana | 54 (68.4) | 31 (73.8) | 23 (62.2) | |
| Cocaine | 7 (8.9) | 3 (7.1) | 4 (10.8) | |
| Methamphetamine | 6 (7.6) | 2 (4.8) | 4 (10.8) | |
| Heroin | 3 (3.8) | 3 (7.1) | 0 (0.0) | |
| Hallucinogens | 4 (5.1) | 1 (2.4) | 3 (8.1) | |
| Inhalants | 4 (5.1) | 1 (2.4) | 3 (8.1) | |
| Sedatives or sleeping pills | 1 (1.3) | 1 (2.4) | 0 (0.0) | |
| DOMC Marijuana or Other Drug Type | 0.335 | |||
| Marijuana | 54 (68.4) | 31 (73.8) | 23 (62.2) | |
| Other | 25 (31.6) | 11 (26.2) | 14 (37.8) | |
| Current Problem Use (SIP) | ||||
| Alcohol | 21 (26.6) | 12 (28.6) | 9 (24.3) | 0.800 |
| Drugs | 43 (54.4) | 20 (47.6) | 23 (62.2) | 0.285 |
1
P-value compares the SO vs. SUSIT group; P<0.05 shown in bold
2
Assessment missing for one participant
3
Sums to greater than 100% because some participants had moderate risk of using multiple substances